Clinical Trial Update: Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy trial comparing Catioprost (unpreserved latanoprost 0.005% emulsion) with Travatan Z for glaucoma and ocular surface disease has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Ocular Surface Disease

Drugs mentioned

• Catioprost (latanoprost emulsion (unpreserved))
• TRAVATAN Z (TRAVOPROST)

Snippet

Sponsor: Santen SAS | Conditions: Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED